Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Metabolite Profiling of [14C]GRT6019 in Healthy Males
NCT07479745Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tegacorat, sponsored by Grünenthal GmbH. Primary endpoints: Cumulative amount of total radioactivity excreted at Day 48, Cumulative amount of total radioactivity excreted expressed as a percentage of the radioactive dose administered at Day 48 and 1 more. Started Mar 2026; status: completed.
02
Drugs
tegacorat
Beyond the preview
Go deeper on NCT07479745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07479745.